NCT05940935|CompletedDMC
Loading search results
Sponsor study identifier
observational
35
1 country
1
Study Start
May 22, 2023
Actual (reported)Primary Completion
June 30, 2023
Actual (reported)Study Completion
August 15, 2023
Actual (reported)The relationship of developing metabolic acidosis with antiepleptic drugs in craniotomy operations
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 15, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 22, 2023
Actual (reported)June 21, 2023
Actual (reported)June 30, 2023
Actual (reported)July 11, 2023
Actual (reported)August 15, 2023
Actual (reported)Preoperative Metabolic Acidosis
The base deficit values in the preoperative, intraoperative and postoperative blood gases taken from the patients and the presence and severity of metabolic acidosis were evaluated. Metabolic acidosis severity was defined by base deficit levels: mild from -3 to -5, moderate from -5 to -10, and severe metabolic acidosis below -10.
Baseline
Intraoperative Metabolic Acidosis
The base deficit values in the preoperative, intraoperative and postoperative blood gases taken from the patients and the presence and severity of metabolic acidosis were evaluated. Metabolic acidosis severity was defined by base deficit levels: mild from -3 to -5, moderate from -5 to -10, and severe metabolic acidosis below -10.
during the operation
Postoperative Metabolic Acidosis
Patients who have used Zonisamide or Topiramate
Patients who have used Lacosamide
Patients who have used Carbamazepine
Patients who have used levetiracetam
The base deficit values in the preoperative, intraoperative and postoperative blood gases taken from the patients and the presence and severity of metabolic acidosis were evaluated. Metabolic acidosis severity was defined by base deficit levels: mild from -3 to -5, moderate from -5 to -10, and severe metabolic acidosis below -10.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients who underwent craniotomy and intracranial surgery at Trakya University Medical Faculty Hospital and used antiepileptic drugs were included in the study as a retrospective file review. The files of 35 patients who met the study criteria were reviewed retrospectively.
Trakya University
Edirne, Centrum, 22030, Turkey (Türkiye)
SEVTAP HEKİMOĞLU ŞAHİN, Professor
Trakya University
35 participants (actual enrollment reported by the registry).
First Submitted
June 21, 2023
First Posted
July 11, 2023
Study Start
May 22, 2023
Actual (reported)Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)
The base deficit values in the preoperative, intraoperative and postoperative blood gases taken from the patients and the presence and severity of metabolic acidosis were evaluated. Metabolic acidosis severity was defined by base deficit levels: mild from -3 to -5, moderate from -5 to -10, and severe metabolic acidosis below -10.
Day 1
Contact the study team to confirm eligibility.
Primary Completion
June 30, 2023
Actual (reported)Study Completion
August 15, 2023
Actual (reported)Last Updated
November 7, 2023
Record last verified: 2023-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: